quetiapine XR
quetiapine XR is a pharmaceutical drug with 22 clinical trials. Historical success rate of 70.0%.
Success Metrics
Based on 14 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
19
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
70.0%
14 of 20 finished
30.0%
6 ended early
0
trials recruiting
22
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.
A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder
Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
Clinical Trials (22)
A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.
A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder
Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
A Study of Quetiapine SR (Seroquel SR) to Treat SSRI-Resistant, Comorbid Panic Disorder Patients
Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia
An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)
Pediatric Bipolar Depression
Quetiapine XR for Cognitive and Functional Disability in Clinically Stable Patients With Bipolar Disorder
The Quietude Study: Quetiapine Use for Agitated Depression
The Effects of Quetiapine (Seroquel XR) on Sleep During Alcohol Abstinence
Comparison of the Subjective Well-being and Tolerability of Quetiapine XR to Risperidone
Clinical Benefits of Seroquel XR in Anxiety Disorder
Schizophrenic Patients in Integrated Care
Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients
Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder
Quetiapine XR in Schizophrenic Patients
Quetiapine in Specific Phobia
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 22